Abstract：Objective To explore the feasibility of 3D printed individualized applicator for the intracavitary HDR-brachytherapy for nasopharyngeal carcinoma. Methods CT scan was performed in 1 case of recurrent rT1 nasopharyngeal carcinoma and 1 case of T2 residual nasopharyngeal carcinoma and the obtained images were transmitted to 3D image processing software. The geometric contour parameters of the nasopharyngeal cavity were obtained and a pipeline was designed to make it close to the recurrent gross tumor volume (rGTV). Individualized cavity applicators were created by using 3D printer. The applicator was inserted into the patient′s nasopharyngeal cavity through oral cavity. The source tube and false source were inserted into the preset pipe of the applicator. CT scan was performed again and the images were transmitted to the 3D brachytherapy planning system. After delineating the target volume and organ at risk, treatment plan was optimized. After completing the first treatment, the applicator was removed. Before second treatment in a few days, CT scan was reviewed to confirm whether the position was correct. Results When the applicator was inserted into the nasopharyngeal cavity, it could be fully aligned with the nasopharyngeal wall and self-fixed without additional fixation measures. Comparing the location of false source in multiple reviews of CT scan, the error was ≤1 mm. No significant discomfort was reported throughout the treatment. In optimized three-dimensional treatment,100% prescription dose curve included the full rGTV, maximum dose of the brain stem and spinal cord was<30% prescription dose. Recurrent patients were given with a prescription dose of DT 40Gy/8 fractions/4 weeks and patients with residual tumors were given with 12Gy/2 fractions/1 week. No tumor recurrence was observed at postoperative 3 months in two cases. Conclusions The 3D printed individualized nasopharyngeal intracavitary applicator has the advantages of self-fixation, accurate location, good repeatability and good patient tolerance. The short-term outcome is effective, whereas its long-term clinical effect and adverse reactions need to be further observed.
Tang Yiqiang,Zeng Lei,Ao Fan et al. Preliminary exploration of 3D printed individualized applicator for 3D-image-guided intracavitary HDR-brachytherapy for nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2020, 29(3): 211-214.
[1] Peng G,Wang T,Yang KY,et al. A prospective,randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs.conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma[J].Radiother Oncol,2012,104(3):286-293. DOI:10.1016/j.radonc.2012.08.013.
[2] Zhang MX,Li J,Shen GP,et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy:a 10-year experience with a large cohort and long follow-up[J]. Eur J Cancer,2015,51(17):2587-2595. DOI:10.1016/j.ejca.2015.08.006.
[3] Lee N,Hoffman R,Phillips TL,et al. Managing nasopharyngeal carcinoma with intracavitary brachytherapy:one institution′s 45-year experience[J]. Brachytherapy,2002,1(2):74-82.
[4] Leung TW,Tung SY,Sze WK,et al. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys,2000,48(5):1331-1338.
[5] Ren YF,Cao XP,Xu J,et al.3D-image-guided high-dose-rate intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma[J]. Radiat Oncol,2013,8:165. DOI:10.1186/1748-717X-8-165.
[6] de Arruda FF,Puri DR,Zhung J,et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma:the Memorial Sloan-Kettering Cancer Center experience[J]. Int J Radiat Oncol Biol Phys,2006,64(2):363-373. DOI:10.1016/j.ijrobp.2005.03.006.
[7] Setton J,Han J,Kannarunimit D,et al. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma[J]. Oral Oncol,2016,53:67-73. DOI:10.1016/j.oraloncology.2015.11.015.
[8] Lee AW,Ng WT,Pan JJ,et al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma[J]. Radiother Oncol,2018,126(1):25-36. DOI:10.1016/j.radonc.2017.10.032.
[9] 中国鼻咽癌分期专家委员会.2010鼻咽癌调强放疗靶区及剂量设计指引专家共识[J]. 中华放射肿瘤学杂志,2011,20(4):267-269. DOI:10.3760/cma.j.issn.1004-4221.2011.04.001.
China Nasopharyngeal Carcinoma Phase Expert Committee.2010 expert consensus on the guidelines for the target area and dose design of nasopharyngeal carcinoma modulated radiotherapy[J]. Chin J Radial Oncol,2011,20(4):267-269. DOI:10.3760/cma.j.issn.1004-4221.2011.04.001.
[10] 李晔雄. 肿瘤放射治疗学[M].5版. 北京:中国协和医科大学出版社,2018.
Li YX. Tumor radiation oncology[M] .5th ed.Beijing:Peking Union Medical University Press,2018.
[11] Ren YF,QuanCheng Zhao,Hui Liu,et al.3D-image-guided HDR-brachytherapy versus 2D HDR-brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma[J]. BMC Cancer,2014,14:894. DOI:10.1186/1471-2407-14-894.
[12] 于浪,连欣,晏俊芳,等.3D打印技术在CT引导宫颈癌术后阴道残端肿瘤近距离治疗中应用[J]. 中华放射肿瘤学杂志,2016,25(9):965-967. DOI:10.3760/cma.j.issn.1004-4221.2016.09.013.
Yu L,Lian X,Yan JF,et al. Application of 3D printing technology in brachytherapy for Vaginal stump tumor after CT-guided cervical cardnoma surgery[J]. Chin J Radial Oncol,2016,25(9):965-967. DOI:10.3760/cma.j.issn.1004-4221.2016.09.013.
2020, Vol. 29 
